KIF2C was shown to act as a tumor antigen that can elicit spontaneous and frequent CD41 T-cell responses of the Th1 type in colorectal cancer, in a process that is influenced by peripheral T-regulatory cells (Gwon et al., 2012). This evidence concerns the gene ITGA2B and neoplasm.